drugset
drugset / Trial / NCT00934947

Burn Healing and Analgesia With Propranolol

NCT00934947 ↗

Phase 2 Completed 45 enrolled University of North Carolina, Chapel Hill
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the ability of propranolol to decrease pain and improve recovery in burn patients with a common genotype.

Timeline

Start
2009-07
Primary completion
2011-02
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 40 mg —
Subject Propranolol Small molecule 120 mg —

Indications

No indication recorded.